Unresectable Huge Sternal and Mediastinal Metastasis of Follicular Thyroid Carcinoma; Radiotherapy as First-line and Palliative Therapy

Abstract

Distant metastases as initial manifestation of follicular thyroid carcinoma is rare. We report a case of an unusual initial presentation of follicular thyroid carcinoma on follow-up. A 52- year-old woman presented with a 12-month history of progressively enlarging mass in the anterior chest wall. The mass was fixed to the chest wall, measuring 12×10 cm in diameter. Computed tomography demonstrated a lobulated soft-tissue mass (17×11×6 cm) destructing sternum and extending into the anterior mediastinum. There was no lung metastasis. Invasion of tumor to the ascending aorta, superior vena cava, and right atrium could not be excluded. Multiple lymph nodes were observed in the supraclavicular regions. Ultrasonography of the thyroid gland showed 46×37 mm nodule in the left lobe with milimetric gross calcifications and cystic-necrotic areas. Hyperthyroidism was detected. Biopsy from this nodule and the sternal mass revealed typical histology of follicular carcinoma. She was considered inoperable. Since there was huge tumor burden and iodinated contrast exposure for several times during evaluation, we decided to treat the patient with external beam radiotherapy (EBRT) rather than radioiodine as first-line therapy. After a course of conventional radiation with 50 Gy in 25 fractions over 4 weeks, encompassing the thyroid bed and the gross disease, tumor regressed remarkably in 6 months. In conclusion, when surgical resection is not possible, EBRT may be used for palliative purpose to obtain local control for extensive disease as first-line therapy. The indications of EBRT for differentiated thyroid cancer still remain poorly defined.

Key words

distant metastases - follicular thyroid cancer - radiotherapy - sternal tumour - unresectable

References

• 1 Bernier MO, Leenhardt L, Hoang C, Aurengo A, Mary JY, Menegaux F, Enkaoua E, Turpin G, Chiras J, Saillant G, Hejblum G. Survival and therapeutic modalities in patients with bone metastases of differentiated thyroid carcinomas.  Journal of Clinical Endocrinology and Metabolism. 2001;  86 1568-1573
• 2 Brierley JD, Tsang RW. External-beam radiation therapy in the treatment of differentiated thyroid cancer.  Semin Surg Oncol. 1999;  16 42-49
• 3 Brierley J, Tsang R, Panzarella T, Bana N. Prognostic factors and the effect of treatment with radioactive iodine and external beam radiation on patients with differentiated thyroid cancer seen at a single institution over 40 years.  Clinical Endocrinology. 2005;  63 418-427
• 4 Brown AP, Greening WP, MacCready VR. et al . Radioiodine treatment of metastatic thyroid carcinoma: the Royal Marsden Hospital experience.  Br J Radiol. 1984;  57 323-327
• 5 Casara D, Rubello D, Saladini G, Gallo V, Masarotto G, Busnardo B. Distant metastases in differentiated thyroid cancer: long-term results of radioiodine treatment and statistical analysis of prognostic factors in 214 patients.  Tumori. 1991;  77 432-436
• 6 Chow SM, Law SC, Mendenhall WM, Au SK, Yau S, Yuen KT, Law CC, Lau WH. Follicular thyroid carcinoma: prognostic factors and the role of radioiodine.  Cancer. 2002a;  95 488-498
• 7 Chow SM, Law SC, Mendenhall WM. et al . Papillary thyroid carcinoma: prognostic factors and the role of radioiodine and external radiotherapy.  Int J Radiat Oncol Biol Phys. 2002b;  52 784-795
• 8 Farahati J, Reiners C, Stuschke M, Müller SP, Stüben G, Sauerwein W, Sack H. Differentiated thyroid cancer. Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT. 4).  Cancer. 1996;  77 172-180
• 9 Ford D, Giridharan S, MacConkey C, Hartley A, Brammer C, Watkinson JC, Glaholm J. External beam radiotherapy in the management of differentiated thyroid cancer.  Clin Oncol. 2003;  15 337-341
• 10 Gilliland FD, Hunt WC, Morris DM, Key CR. Prognostic factors for thyroid carcinoma. A population-based study of 15698 cases from the Surveillance, Epidemiology and End Results (SEER) Program 1973–1991.  Cancer. 1997;  79 564-573
• 11 Grebe SK, Hay ID. Follicular thyroid cancer.  Endocrinol Metab Clin North Am. 1995;  24 761-801
• 12 Haq M, Harmer C. Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome.  Clinical Endocrinology. 2005;  63 87-93
• 13 Mazzaferri EL. An overview of the management of papillary and follicular thyroid carcinoma.  Thyroid. 1999;  9 421-427
• 14 Mazzaferri EL. Radioiodine and other treatment and outcomes. In: Braverman LE, Utiger RD, Philadelphia PA, (Eds). The Thyroid. USA, Lippincott Williams & Wilkins 2000: 904-929
• 15 Meadows KM, Amdur RJ, Morris CG, Villaret DB, Mazzaferri EL, Mendenhall WM. External beam radiotherapy for differentiated thyroid cancer.  American Journal of Otolaryngology – Head and Neck Medicine and Surgery. 2006;  27 24-28
• 16 Mizukami Y, Michigishi T, Nonomura A. et al . Distant metastases in differentiated thyroid carcinoma: a clinical and pathologic study.  Hum Pathol. 1990;  21 283-290
• 17 Segal K, Avigail A, Lubin E, Shpitzer T. Follicular carcinoma of the thyroid.  Head Neck. 1994;  16 533-538
• 18 Shaha AR, Shah JP, Loree TR. Differentiated thyroid cancer presenting initially with distant metastasis.  Am J Surg. 1997;  174 474-476
• 19 Tsang RW, Brierley JD, Simpson WJ, Panzarella T, Gospodarowicz MK, Sutcliffe SB. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.  Cancer. 1998;  82 375-388
• 20 Tubiana M, Haddad E, Schlumberger M. et al . External radiotherapy in thyroid cancers.  Cancer. 1985;  55 ((9 Suppl)) 2062-2071
• 21 Tuttle M, Robbins R, Larson SM, Strauss HW. Challenging cases in thyroid cancer: a multidisciplinary approach.  Eur J Nucl Med Mol Imaging. 2004;  31 605-612

Correspondence